newsfilter
← Latest News
Business Wire·

Graphite Bio Announces Formation of Scientific Advisory Board

Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage, next-generation gene editing company focused on developing therapies that harness targeted gene integration to treat or cure serious diseases, today announced the formation of its Scientific Advisory B